Steve Mann

1.4k total citations
25 papers, 1.1k citations indexed

About

Steve Mann is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Steve Mann has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 5 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Steve Mann's work include Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Steve Mann is often cited by papers focused on Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Steve Mann collaborates with scholars based in Canada, United Kingdom and United States. Steve Mann's co-authors include Gary Remington, Shitij Kapur, George Foussias, Chekkera Shammi, Konstantine K. Zakzanis, Adria Giacca, Araba Chintoh, Robert van Reekum, David C. Mamo and Paul Fletcher and has published in prestigious journals such as American Journal of Psychiatry, Food and Chemical Toxicology and Schizophrenia Research.

In The Last Decade

Steve Mann

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Mann Canada 17 684 177 174 161 143 25 1.1k
Atheeshaan Arumuham United Kingdom 8 517 0.8× 88 0.5× 117 0.7× 177 1.1× 126 0.9× 19 907
René S. Kahn Netherlands 5 805 1.2× 141 0.8× 64 0.4× 85 0.5× 118 0.8× 8 1.1k
Nigel Bark United States 13 666 1.0× 206 1.2× 154 0.9× 132 0.8× 45 0.3× 30 1.2k
Maosheng Fang China 15 523 0.8× 66 0.4× 132 0.8× 264 1.6× 214 1.5× 29 974
Alma Mihaljević-Peleš Croatia 19 390 0.6× 150 0.8× 89 0.5× 115 0.7× 78 0.5× 58 943
Luke Vano United Kingdom 5 545 0.8× 60 0.3× 109 0.6× 178 1.1× 129 0.9× 10 823
M. Andrew Berisford United States 9 852 1.2× 97 0.5× 109 0.6× 402 2.5× 169 1.2× 11 1.2k
Marie‐France Poirier France 17 412 0.6× 195 1.1× 116 0.7× 100 0.6× 45 0.3× 34 964
M. Kâzım Yazıcı Türkiye 19 710 1.0× 85 0.5× 78 0.4× 58 0.4× 90 0.6× 43 1.1k
José María Pelayo‐Terán Spain 23 1.3k 1.9× 150 0.8× 77 0.4× 154 1.0× 123 0.9× 57 1.6k

Countries citing papers authored by Steve Mann

Since Specialization
Citations

This map shows the geographic impact of Steve Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Mann more than expected).

Fields of papers citing papers by Steve Mann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Mann. The network helps show where Steve Mann may publish in the future.

Co-authorship network of co-authors of Steve Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Mann. A scholar is included among the top collaborators of Steve Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Mann. Steve Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mann, Steve, et al.. (2025). Smart Rollator Walker for Enhanced Mobility. 1–6.
2.
Foussias, George, Ishraq Siddiqui, Gagan Fervaha, et al.. (2015). Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia. Schizophrenia Research. 166(1-3). 276–282. 51 indexed citations
3.
Hahn, Margaret, Araba Chintoh, Gary Remington, et al.. (2013). Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: An animal model. European Neuropsychopharmacology. 24(3). 448–458. 21 indexed citations
4.
Yılmaz, Zeynep, Clement C. Zai, Rudi Hwang, et al.. (2012). Antipsychotics, dopamine D2 receptor occupancy and clinical improvement in schizophrenia: A meta-analysis. Schizophrenia Research. 140(1-3). 214–220. 39 indexed citations
5.
Mann, Steve, Araba Chintoh, Adria Giacca, et al.. (2012). Chronic olanzapine administration in rats: Effect of route of administration on weight, food intake and body composition. Pharmacology Biochemistry and Behavior. 103(4). 717–722. 20 indexed citations
6.
Fervaha, Gagan, Celine Teo, Steve Mann, et al.. (2012). Poster #195 EXAMINING LEVELS OF ANTIPSYCHOTIC ADHERENCE TO BETTER UNDERSTAND NONADHERENCE IN PATIENTS WITH SCHIZOPHRENIA. Schizophrenia Research. 136. S161–S161. 1 indexed citations
7.
Remington, Gary, Steve Mann, Patrick N. McCormick, et al.. (2011). Modeling chronic olanzapine exposure using osmotic minipumps: Pharmacological limitations. Pharmacology Biochemistry and Behavior. 100(1). 86–89. 10 indexed citations
8.
Hahn, Margaret, Araba Chintoh, Adria Giacca, et al.. (2011). Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model. Schizophrenia Research. 131(1-3). 90–95. 61 indexed citations
9.
Foussias, George, Steve Mann, Konstantine K. Zakzanis, et al.. (2011). Prediction of longitudinal functional outcomes in schizophrenia: The impact of baseline motivational deficits. Schizophrenia Research. 132(1). 24–27. 116 indexed citations
10.
Remington, Gary, Shitij Kapur, George Foussias, et al.. (2011). Tetrabenazine Augmentation in Treatment-Resistant Schizophrenia. Journal of Clinical Psychopharmacology. 32(1). 95–99. 20 indexed citations
11.
Foussias, George, Steve Mann, Konstantine K. Zakzanis, et al.. (2010). MOTIVATIONAL DEFICITS IN SCHIZOPHRENIA: CROSS-SECTIONAL AND LONGITUDINAL RELATIONSHIPS WITH FUNCTIONING. Schizophrenia Research. 117(2-3). 303–304. 2 indexed citations
12.
Remington, Gary, Philip Seeman, Alan Feingold, et al.. (2010). “Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia. The Journal of Clinical Psychiatry. 72(8). 1042–1048. 53 indexed citations
13.
Foussias, George, Steve Mann, Konstantine K. Zakzanis, Robert van Reekum, & Gary Remington. (2009). Motivational deficits as the central link to functioning in schizophrenia: A pilot study. Schizophrenia Research. 115(2-3). 333–337. 89 indexed citations
14.
Chintoh, Araba, Steve Mann, Loretta Lam, et al.. (2009). Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model. Schizophrenia Research. 108(1-3). 127–133. 99 indexed citations
15.
Chintoh, Araba, Steve Mann, Tony K.T. Lam, Adria Giacca, & Gary Remington. (2008). Insulin resistance following continuous, chronic olanzapine treatment: An animal model. Schizophrenia Research. 104(1-3). 23–30. 44 indexed citations
16.
Chintoh, Araba, Steve Mann, Loretta Lam, et al.. (2008). Insulin Resistance and Decreased Glucose-Stimulated Insulin Secretion After Acute Olanzapine Administration. Journal of Clinical Psychopharmacology. 28(5). 494–499. 77 indexed citations
17.
Remington, Gary, David C. Mamo, Alain Labelle, et al.. (2006). A PET Study Evaluating Dopamine D2 Receptor Occupancy for Long-Acting Injectable Risperidone. American Journal of Psychiatry. 163(3). 396–401. 88 indexed citations
18.
Mamo, David C., Shitij Kapur, Chekkera Shammi, et al.. (2004). A PET Study of Dopamine D2 and Serotonin 5-HT2 Receptor Occupancy in Patients With Schizophrenia Treated With Therapeutic Doses of Ziprasidone. American Journal of Psychiatry. 161(5). 818–825. 144 indexed citations
19.
20.
Mann, Steve, et al.. (2000). A combined chronic toxicity/carcinogenicity study of sucralose in Sprague–Dawley rats. Food and Chemical Toxicology. 38. 71–89. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atheeshaan Arumuham Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by Nigel Bark Breakdown of academic impact, for papers by Maosheng Fang Breakdown of academic impact, for papers by Alma Mihaljević-Peleš Breakdown of academic impact, for papers by Luke Vano Breakdown of academic impact, for papers by M. Andrew Berisford Breakdown of academic impact, for papers by Marie‐France Poirier Breakdown of academic impact, for papers by M. Kâzım Yazıcı Breakdown of academic impact, for papers by José María Pelayo‐Terán
Rankless by CCL
2026